ArticleJHLT open2025
Donor-derived infections in heart and lung transplant recipients.
Article in JHLT open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Donor-derived viral infections: the usual suspects and the new kids on the block.Transplant international : official journal of the European Society for Organ Transplantation · 2026Review
- Polymicrobial Multidrug-Resistant Infection and Fatal Bowel Ischemic Perforation After Urgent Heart Transplantation in a VA-ECMO-Bridged Recipient: A Case Report.Infection and drug resistance · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heart and lung transplantation are life-saving treatments for patients with end-stage organ disease. Donor-derived infections are common and can be expected or unexpected. The lung is exposed to the external environment and transplanted with an intact microbiome, which can include community and nosocomial bacterial, viral, and fungal pathogens. This includes not only well-recognized scenarios, such as bacteria with or without multidrug resistance, respiratory viruses including SARS-CoV-2, molds, and tuberculous/nontuberculous mycobacteria, but also emerging pathogens, such as the mollicutes. The heart is the only transplanted organ that is a muscle and in direct contact with the bloodstream. These factors make donor-derived endocarditis, toxoplasmosis, and Chagas disease particularly relevant. This article aims to review some key established and emerging donor-derived infections that are of particular significance to heart and lung transplant recipients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.